PACB Pacific Biosciences of California

USD 3.75 0.03 0.8064519999999999
Icon

Pacific Biosciences of California (PACB) Stock Analysis and Price Targets

COMMON STOCK | Medical Devices | NSD
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.75

+0.03 (+0.81)%

USD 0.99B

6.57M

USD 10.46(+178.89%)

USD 0.00 (-100.00%)

Icon

PACB

Pacific Biosciences of California (USD)
COMMON STOCK | NSD
USD 3.75
0.00 0
Take a Tour
stockTargetAdvisor

Buy

Average Analyst
Rating
stockTargetAdvisor

Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 0.99B

USD 0.00 (-100.00%)

USD 3.75

Pacific Biosciences of California (PACB) Stock Forecast

Show ratings and price targets of :
USD 10.46
(+178.89%)

Based on the Pacific Biosciences of California stock forecast from 8 analysts, the average analyst target price for Pacific Biosciences of California is USD 10.46 over the next 12 months. Pacific Biosciences of California’s average analyst rating is Buy . Stock Target Advisor’s own stock analysis of Pacific Biosciences of California is Bearish, which is based on 2 positive signals and 6 negative signals. At the last closing, Pacific Biosciences of California’s stock price was USD 3.75. Pacific Biosciences of California’s stock price has changed by -2.34% over the past week, -32.68% over the past month and -58.93% over the last year.

No recent analyst target price found for Pacific Biosciences of California
No recent average analyst rating found for Pacific Biosciences of California

Company Overview Pacific Biosciences of California

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and v...Read More

https://www.pacb.com

1305 O?Brien Drive, Menlo Park, CA, United States, 94025

796

December

USD

USA

Adjusted Closing Price for Pacific Biosciences of California (PACB)

Loading...

Unadjusted Closing Price for Pacific Biosciences of California (PACB)

Loading...

Share Trading Volume for Pacific Biosciences of California Shares

Loading...

Compare Performance of Pacific Biosciences of California Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PACB

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Pacific Biosciences of California (Sector: Medical Devices )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ABT
Abbott Laboratories +0.18 (+0.16%) USD196.91B 34.81 19.47

ETFs Containing PACB

Symbol Name PACB's Weight Expense Ratio Price(Change) Market Cap

Frequently Asked Questions About Pacific Biosciences of California (PACB) Stock

Based on ratings from 8 analysts Pacific Biosciences of California's stock is Buy . Stock Target Advisor's fundamental analysis is Bearish. The stock has 7 buy, sell and 5 hold ratings.

Unfortunately we do not have enough data on PACB's stock to indicate if its a good dividend stock.

Based on targets from 8 analysts, the average taret price for PACB is USD 10.46 over the next 12 months. The maximum analyst target price is USD 15 while the minimum anlayst target price is USD 6.5.

PACB stock's Price/Earning ratio is 194.47. Our analysis grades PACB stock's Price / Earning ratio at F. This means that PACB stock's Price/Earning ratio is above 85% of the stocks in the Medical Devices sector in the NSD exchange. Based on this PACB may be a overvalued for its sector.

The last closing price of PACB's stock was USD 3.75.

The most recent market capitalization for PACB is USD 0.99B.

Based on targets from 8 analysts, the average taret price for PACB is projected at USD 10.46 over the next 12 months. This means that PACB's stock price may go up by +178.89% over the next 12 months.

We can't find any ETFs which contains Pacific Biosciences of California's stock.

As per our most recent records Pacific Biosciences of California has 796 Employees.

Pacific Biosciences of California's registered address is 1305 O?Brien Drive, Menlo Park, CA, United States, 94025. You can get more information about it from Pacific Biosciences of California's website at https://www.pacb.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...